NO0010598683
© Globe Newswire
15.12.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: Cancellation of Subsequent Offering – Update on completion of Private Placement
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN....
Themefolio
Profiler
Peergroup
© Globe Newswire
21.11.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION
News Preview
Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC"), has subscribed for 368,320 Offer shares in the Subsequent Offering and Mr. Baldegger will hold 3,616,296 shares in HBC after the share capital is registered, equal to approximately 0.92 % of the total outstanding A-shares with voting rights. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.11.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: RESULTS OF SUBSEQUENT OFFERING
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
20.11.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: Extraordinary General Meeting completed
News Preview
Hofseth BioCare ASA held an Extraordinary General Meeting on 20 November 2025. All proposals were resolved as presented in the notice issued on 30 October 2025....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
20.11.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: LAST DAY OF SUBSCRIPTION PERIOD IN SUBSEQUENT OFFERING
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.11.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: HBC ANNOUNCES STRATEGIC PRODUCT PARTNERSHIP WITH JAMES LAVALLE & METABOLIC ELITE
News Preview
Hofseth BioCare (HBC), a global leader in sustainable marine-based nutrition, today announced a strategic product partnership with Metabolic Elite, with formulations being guided by key opinion leader and nutrition expert Jim LaValle. The collaboration unites HBC’s rigorously tested nutritional ingredients, including award-winning ProGo® bioactive...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: Publication of the Prospectus – Start of the Subscription Period for the Subsequent Offering
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: Terms of the Subsequent Offering
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: THIRD QUARTER 2025 FINANCIAL REPORT
News Preview
HBC recorded total operating revenues of NOK 54.9 million in the third quarter of 2025, compared to NOK 67.9 million in the same period last year. Net operating revenues were NOK 54.8 million, reflecting lower commodity prices and a weaker U.S. dollar during the quarter....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING
News Preview
Reference is made to the stock exchange announcement by Hofseth BioCare ASA ("HBC" or the "Company") on 27 October 2025 regarding (i) the completion of a private placement (the "Private Placement") of new shares in the Company the "Offer Shares"), the completion of which by delivery of Offer Shares in tranche 2 (the "T2 Offer Shares") is subject to...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: Mandatory Notification of Trade
News Preview
Reference is made to the stock exchange announcement by Hofseth Biocare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placement (the "Private Placement") of new shares in the Company....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
HBC
LISTED
OSL
Ex. Subsequent Offering Today
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
27.10.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: Key Information Relating to Subsequent Offering
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: Disclosures of Large Shareholdings
News Preview
Reference is made to the stock exchange announcement by Hofseth BioCare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placement (the "Private Placement") of new shares in the Company....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: Private placement successfully placed
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN....
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: USD 5 Million Divestment in Aecorbio
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN....
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
HBC
LISTED
OSL
Hofseth BioCare ASA: Contemplated Private Placement and Partial Divestment of Shares in Aecorbio
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN....
Themefolio
Profiler
Peergroup
© Globe Newswire
17.09.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: AECORBIO SECURES A FURTHER $1.5M AT A $30M VALUATION FOR ONGOING FT-002A PEPTIDE DEVELOPMENT IN PROSTATE CANCER
News Preview
AecorBio Inc., formerly known as HBC Immunology Inc, has successfully completed a further equity financing round of $1.5m from existing and new investors at a company valuation of $30 million. This funding will enable AecorBio to complete the investigational work of its lead peptide candidate FT-002a, in advanced prostate cancer, to enable an Inves...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: ProGo, the world’s first consumer health GLP-1 & GIP receptor agonist with muscle mass protection via inhibition of Myostatin and Activin A pathways
News Preview
HBC has today released a whitepaper demonstrating how its bioactive peptide ingredient ProGo® uniquely provides complete GLP-1 support....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: HBC onboards former Head of Nestle Health Science Asia, Oceania, Middle East and Africa Region, Paul Bruhn
News Preview
HBC is delighted to announce the appointment of Paul Bruhn as Head of New Business Development. Mr Bruhn has over 25 years’ experience in healthcare and the medical nutrition space spanning Novartis Medical Nutrition and Nestle Health Science....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.08.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: SECOND QUARTER 2025 FINANCIAL REPORT
News Preview
HBC recorded total operating revenues of NOK 68.4 million in the second quarter of 2025, compared to NOK 80.4 million in the same period last year. Net operating revenues were NOK 67.8 million, compared to NOK 72.2 million in the same quarter last year. Total operating revenue for the first six months of 2025 was NOK 129.3 million (NOK 132.8 millio...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.07.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: HBC’s ProGo® has won Ingredient of the Year for Healthy Aging at the prestigious Nutraingredients USA awards ceremony in Chicago
News Preview
According to the judges, the winning factors placing ProGo® well ahead of the competition are its unique ability to activate GLP-1 and GIP receptors, coupled with its unrivalled sustainability credentials including Upcycled Certified by WFCF (Where Food Comes From). Most significantly, these benefits are supported and evidenced through two clinical...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.05.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: FIRST QUARTER 2025 FINANCIAL REPORT
News Preview
HBC recorded total operating revenues of NOK 60.9 million in the first quarter of 2025, compared to NOK 52.4 million in the same period last year. Net operating revenues were NOK 60.7 million, reflecting a 15% increase from Q1 2024 (NOK 52.1 million), driven by continued growth in higher-margin human and pet health segments, despite early-quarter p...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: NESTLÉ GARDEN OF LIFE LAUNCHES HBC OMEGO® FULL SPECTRUM OMEGAS IN THE US
News Preview
Nestlé-owned Garden of Life has launched OmeGo® Full Spectrum Omegas on Amazon in the US. Branded as “Norwegian Salmon Oil”, it retains the complete balance and nutritional profile of fresh Atlantic salmon in a softgel format....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: SUCCESSFUL PLACEMENT OF NEW CHF-DENOMINATED UNSECURED BONDS
News Preview
Reference is made to the stock exchange notice published by Hofseth BioCare ASA (the "Company") on 10 March 2025 regarding a contemplated bond issuance....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.04.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: HBC ANNUAL REPORT 2024
News Preview
The Board of Directors of Hofseth BioCare ASA ("HBC") has approved the financial statements for 2024, and HBC has today published the Annual Report and Sustainability Report for 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.03.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: CONTEMPLATING UNSECURED BOND ISSUANCE
News Preview
Hofseth BioCare ASA has retained Novum Asset Management AG to investigate the potential issuance of CHF-denominated unsecured bonds with an expected volume of up to CHF 8 million, towards investors in Switzerland and Liechtenstein. Further, the Company may contact investors in Norway directly. The Company targets a tenor of three years for the Bond...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.02.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
News Preview
Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC") holds 1,500,000 shares personally and has held 1,747,976 shares indirectly through the Bonafide fund. Redemption of the fund has led to transfer of his indirect holdings to his personal account, and hence Mr. Baldegger now personally holds 3,247...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.02.2025
HBC
LISTED
OSL
Hofseth Biocare ASA: FOURTH QUARTER & FULL YEAR 2024 FINANCIAL REPORT
News Preview
HBC achieved full-year sales revenue of NOK 256.8 million, a 35% increase from 2023, with strong momentum in higher-margin B2B human nutrition. The shift towards premium products, particularly CalGo® and OmeGo®, contributed to the revenue boost, while gross margins improved across all segments....
Themefolio
Profiler
Peergroup
© Globe Newswire
12.12.2024
HBC
LISTED
OSL
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
News Preview
Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC") has today purchased 700,000 shares in HBC at an average price of NOK 1.202837 per share....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.12.2024
HBC
LISTED
OSL
Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity
News Preview
Hofseth BioCare ASA ("HBC" or the "Company", and together with its consolidated subsidiaries, the "Group") is pleased to announce a Board resolution to start a project to build a second hydrolysis plant in Berkåk, Norway through HBC Berkåk AS ("HBC Berkåk"), a wholly owned subsidiary of the Company....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2024
HBC
LISTED
OSL
Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT
News Preview
HBC had gross operating revenues of NOK 67.9m (49.9m) in the third quarter and NOK 200.6m (171.1m) in the first nine months. The operating loss (EBITDA) for the quarter was NOK -21.0m (-16.2m) and NOK -39.2m (-26.3m) for the first nine months. Operating result (EBIT) amounted to NOK -30.5m (-25.2m) in the third quarter 2024. Cash and cash equivalen...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2024
HBC
LISTED
OSL
Hofseth Biocare ASA: CFO RESIGNATION
News Preview
Christel Elise Kanli has decided to step down as Chief Financial Officer (CFO) of Hofseth BioCare ASA (“HBC”) to pursue opportunities outside of the company....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2024
HBC
LISTED
OSL
Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT
News Preview
Ålesund, Norway, 8 October 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.08.2024
HBC
LISTED
OSL
Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT
News Preview
HBC had gross operating revenues of NOK 80.4m (76.4m) in the second quarter and NOK 132.8m (121.2m) for the half year. Adjusted for the sale of assets in the second quarter, sales revenues were NOK 72.2m (50.7m) for the quarter, representing an increase compared to the same quarter in 2023 of 42 percent....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.08.2024
HBC
LISTED
OSL
Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY
News Preview
Ålesund, Norway, 14 August, 2024 - Hofseth BioCare (HBC), a leader in science-led marine nutrition, proudly announces compelling new findings from a recent study on the benefits of its enzymatically liberated salmon oil, OmeGo®, for COVID-19 recovery....
Themefolio
Profiler
Peergroup
© Globe Newswire
02.07.2024
HBC
LISTED
OSL
Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.
News Preview
Ålesund, 02.07.24, Hofseth BioCare ASA ("HBC" or the "Company"), a global leader in marine lipid and peptide research, today announces the decision to transfer its eosinophil-targeting drug candidate MA-022a to its majority-owned subsidiary HBC Immunology Inc. ("HBCI"). The patent underlying the project has been valued by KWC AS at $4.5m (based on...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2024
HBC
LISTED
OSL
Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
News Preview
Hofseth BioCare ASA (HBC) is delighted to announce the appointment of Lithy One-Health Group Technology Co. Ltd (Lithy) as an additional distributor in China....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.05.2024
HBC
LISTED
OSL
Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT
News Preview
The first quarter of 2024 continued on the positive trend for HBC. Sales revenues came in at NOK 52m vs NOK 44m last year, a growth of 17 % YoY. The underlying growth we are seeing is coming from both the ingredients business and finished products channels....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
